 Kimberly Kelsay
Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychotherapy | 1 | 2021 | 164 | 0.620 |
Why?
| | Dermatitis, Atopic | 4 | 2010 | 325 | 0.570 |
Why?
| | Child Psychiatry | 1 | 2017 | 35 | 0.540 |
Why?
| | Cognition | 1 | 2021 | 1189 | 0.400 |
Why?
| | Asthma | 4 | 2012 | 2285 | 0.390 |
Why?
| | Pituitary-Adrenal System | 2 | 2012 | 161 | 0.360 |
Why?
| | Hypothalamo-Hypophyseal System | 2 | 2012 | 196 | 0.350 |
Why?
| | Life Change Events | 1 | 2012 | 153 | 0.350 |
Why?
| | Hydrocortisone | 2 | 2012 | 317 | 0.330 |
Why?
| | Leukotriene Antagonists | 1 | 2009 | 43 | 0.320 |
Why?
| | Suicide | 2 | 2023 | 646 | 0.320 |
Why?
| | Acetates | 1 | 2009 | 100 | 0.310 |
Why?
| | Pediatrics | 1 | 2017 | 1119 | 0.310 |
Why?
| | Quinolines | 1 | 2009 | 176 | 0.290 |
Why?
| | Internship and Residency | 1 | 2017 | 1131 | 0.270 |
Why?
| | Sleep Wake Disorders | 2 | 2010 | 283 | 0.260 |
Why?
| | Patient Compliance | 1 | 2010 | 586 | 0.250 |
Why?
| | Anti-Asthmatic Agents | 1 | 2009 | 391 | 0.240 |
Why?
| | Depression | 3 | 2021 | 1402 | 0.230 |
Why?
| | Body Image | 1 | 2005 | 95 | 0.220 |
Why?
| | Stress, Psychological | 1 | 2012 | 1112 | 0.210 |
Why?
| | Personal Satisfaction | 1 | 2005 | 210 | 0.200 |
Why?
| | Suicidal Ideation | 2 | 2023 | 522 | 0.200 |
Why?
| | Primary Health Care | 4 | 2023 | 1741 | 0.200 |
Why?
| | Capacity Building | 1 | 2021 | 62 | 0.170 |
Why?
| | Food Hypersensitivity | 1 | 2003 | 182 | 0.160 |
Why?
| | Bias | 1 | 2021 | 221 | 0.160 |
Why?
| | Quality of Life | 1 | 2010 | 2847 | 0.150 |
Why?
| | Saliva | 2 | 2012 | 242 | 0.130 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2017 | 258 | 0.110 |
Why?
| | Humans | 17 | 2023 | 136899 | 0.100 |
Why?
| | Attention | 1 | 2016 | 453 | 0.100 |
Why?
| | Cognition Disorders | 1 | 2016 | 517 | 0.100 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2016 | 423 | 0.090 |
Why?
| | Child | 10 | 2023 | 21896 | 0.090 |
Why?
| | Object Attachment | 1 | 2012 | 43 | 0.090 |
Why?
| | Pruritus | 1 | 2010 | 61 | 0.080 |
Why?
| | Clinical Competence | 1 | 2017 | 1086 | 0.080 |
Why?
| | Cyclopropanes | 1 | 2009 | 89 | 0.080 |
Why?
| | Risk | 1 | 2012 | 905 | 0.080 |
Why?
| | Interdisciplinary Communication | 1 | 2010 | 192 | 0.080 |
Why?
| | Parent-Child Relations | 1 | 2012 | 272 | 0.080 |
Why?
| | Sulfides | 1 | 2009 | 99 | 0.080 |
Why?
| | Anti-Allergic Agents | 1 | 2008 | 46 | 0.070 |
Why?
| | Dermatologic Agents | 1 | 2008 | 69 | 0.070 |
Why?
| | Self Report | 1 | 2012 | 827 | 0.070 |
Why?
| | Adolescent | 6 | 2023 | 21402 | 0.070 |
Why?
| | Doxepin | 1 | 2006 | 1 | 0.070 |
Why?
| | Histamine H1 Antagonists | 1 | 2006 | 30 | 0.060 |
Why?
| | Clonidine | 1 | 2006 | 28 | 0.060 |
Why?
| | Social Support | 1 | 2010 | 614 | 0.060 |
Why?
| | Prevalence | 2 | 2023 | 2709 | 0.060 |
Why?
| | Anti-Infective Agents | 1 | 2008 | 255 | 0.060 |
Why?
| | Melatonin | 1 | 2006 | 152 | 0.060 |
Why?
| | Hypnotics and Sedatives | 1 | 2006 | 193 | 0.060 |
Why?
| | Incidence | 1 | 2010 | 2783 | 0.050 |
Why?
| | Anxiety | 1 | 2010 | 1039 | 0.050 |
Why?
| | Cross Reactions | 1 | 2003 | 133 | 0.050 |
Why?
| | Mass Screening | 2 | 2021 | 1262 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2003 | 117 | 0.050 |
Why?
| | Surveys and Questionnaires | 3 | 2021 | 5730 | 0.050 |
Why?
| | Clinical Laboratory Techniques | 1 | 2003 | 97 | 0.050 |
Why?
| | Europe | 1 | 2003 | 413 | 0.050 |
Why?
| | Immune System | 1 | 2003 | 177 | 0.050 |
Why?
| | Parents | 2 | 2008 | 1361 | 0.040 |
Why?
| | Mental Disorders | 1 | 2009 | 1080 | 0.040 |
Why?
| | Psychology, Child | 1 | 2000 | 38 | 0.040 |
Why?
| | Infant | 2 | 2012 | 9408 | 0.040 |
Why?
| | Risk Assessment | 1 | 2009 | 3432 | 0.040 |
Why?
| | Hypersensitivity | 1 | 2003 | 256 | 0.040 |
Why?
| | Prospective Studies | 1 | 2012 | 7543 | 0.040 |
Why?
| | Gender Identity | 1 | 2000 | 124 | 0.040 |
Why?
| | Stress, Physiological | 1 | 2003 | 444 | 0.040 |
Why?
| | Pediatricians | 1 | 2021 | 131 | 0.040 |
Why?
| | Child Behavior Disorders | 1 | 2000 | 143 | 0.040 |
Why?
| | Sex Factors | 1 | 2005 | 2067 | 0.040 |
Why?
| | Algorithms | 1 | 2006 | 1695 | 0.040 |
Why?
| | Male | 7 | 2016 | 67308 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2003 | 744 | 0.040 |
Why?
| | Child Behavior | 1 | 2000 | 247 | 0.040 |
Why?
| | Female | 7 | 2016 | 72703 | 0.040 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2006 | 843 | 0.030 |
Why?
| | Risk Factors | 1 | 2010 | 10313 | 0.030 |
Why?
| | Young Adult | 1 | 2012 | 13157 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 2 | 1990 | 560 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2021 | 1018 | 0.030 |
Why?
| | Child, Preschool | 3 | 2016 | 11013 | 0.020 |
Why?
| | Prolactin | 1 | 1990 | 100 | 0.020 |
Why?
| | Chromosome Deletion | 1 | 1990 | 115 | 0.020 |
Why?
| | Gene Expression Regulation, Fungal | 1 | 1990 | 73 | 0.020 |
Why?
| | Severity of Illness Index | 2 | 2008 | 2833 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2008 | 434 | 0.020 |
Why?
| | Genes, Regulator | 1 | 1987 | 37 | 0.020 |
Why?
| | Genes, Fungal | 1 | 1987 | 53 | 0.020 |
Why?
| | Genes | 1 | 1987 | 230 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2023 | 15514 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 1990 | 1255 | 0.010 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2006 | 243 | 0.010 |
Why?
| | Respiratory Function Tests | 1 | 2006 | 596 | 0.010 |
Why?
| | Cost of Illness | 1 | 2006 | 302 | 0.010 |
Why?
| | Skin Tests | 1 | 2003 | 100 | 0.010 |
Why?
| | Specimen Handling | 1 | 2003 | 178 | 0.010 |
Why?
| | Peptides | 1 | 1987 | 981 | 0.010 |
Why?
| | Projective Techniques | 1 | 2000 | 3 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2008 | 3282 | 0.010 |
Why?
| | Internal-External Control | 1 | 2000 | 71 | 0.010 |
Why?
| | Home Care Services | 1 | 2003 | 254 | 0.010 |
Why?
| | Sex Distribution | 1 | 2000 | 378 | 0.010 |
Why?
| | Aggression | 1 | 2000 | 210 | 0.010 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2000 | 555 | 0.010 |
Why?
| | Recombinant Proteins | 2 | 1990 | 1357 | 0.010 |
Why?
| | Molecular Sequence Data | 2 | 1990 | 2901 | 0.010 |
Why?
| | Base Sequence | 2 | 1990 | 2180 | 0.010 |
Why?
| | Amino Acid Sequence | 2 | 1990 | 2143 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2008 | 10768 | 0.010 |
Why?
| | Restriction Mapping | 1 | 1990 | 76 | 0.010 |
Why?
| | beta-Galactosidase | 1 | 1990 | 78 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1990 | 536 | 0.000 |
Why?
| | Plasmids | 1 | 1990 | 363 | 0.000 |
Why?
| | Mating Factor | 1 | 1987 | 3 | 0.000 |
Why?
| | Pheromones | 1 | 1987 | 31 | 0.000 |
Why?
| | Crosses, Genetic | 1 | 1987 | 137 | 0.000 |
Why?
| | Protein Conformation | 1 | 1990 | 930 | 0.000 |
Why?
| | Temperature | 1 | 1990 | 680 | 0.000 |
Why?
| | Escherichia coli | 1 | 1990 | 815 | 0.000 |
Why?
| | Gene Expression | 1 | 1990 | 1505 | 0.000 |
Why?
| | Genetic Variation | 1 | 1990 | 986 | 0.000 |
Why?
| | Genotype | 1 | 1987 | 1906 | 0.000 |
Why?
|
|
Kelsay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|